Impact of PCSK9 and acid ceramidase on obese hypothyroidism female patients
Main Article Content
Abstract
Proprotein Convertase subtilisin Kexin type 9 (PCSK9) is a serine protease composed of 692 residues. Acid ceramidase is an enzyme that hydrolyzed ceramide to sphingosine and fatty acids
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Beynon, M. E., & Pinneri, K. (2016). An overview of the thyroid gland and thyroid-related
deaths for the forensic pathologist. Academic forensic pathology, 6(2), 217-236.
Aati, E. K., & Al-Ali, Z. A. (2020). Effect of hypothyroidism on lipid profile in women at Misan
City/Iraq. Med J Babylon, 17(1), 1.
Samir, Q., & Hameed, M. (2019). Influence of Thyroid Stimulating Hormone on Liver Enzymes
Levels in Serum of Thyroid Disorder Iraqi Patients. Al-Nahrain Journal of Science, 22(3), 50-
Tumakov, D. N., & Fadeeva, E. V. (2021). Mathematical model of thyroid gland functioning as
a follicles system. Archivos Venezolanos de Farmacología y Terapéutica, 40(1), 15-19.
Schwartz, G. G., Steg, P. G., Szarek, M., Bhatt, D. L., Bittner, V. A., Diaz, R., ... & Zeiher, A. M.
(2018). Alirocumab and cardiovascular outcomes after acute coronary syndrome. New
England Journal of Medicine, 379(22), 2097-2107.
Katsuki, S., K. Jha, P., Lupieri, A., Nakano, T., Passos, L. S., Rogers, M. A., ... & Aikawa, M.
(2022). Proprotein convertase subtilisin/kexin 9 (PCSK9) promotes macrophage activation via
LDL receptor-independent mechanisms. Circulation research, 131(11), 873-889.
Schmidt, A. F., Pearce, L. S., Wilkins, J. T., Overington, J. P., Hingorani, A. D., & Casas, J. P.
(2017). PCSK9 monoclonal antibodies for the primary and secondary prevention of
cardiovascular disease. Cochrane Database of Systematic Reviews, (4).
Ferlinz, K., Kopal, G., Bernardo, K., Linke, T., Bär, J., Breiden, B., ... & Sandhoff, K. (2001).
Human acid ceramidase: processing, glycosylation, and lysosomal targeting. Journal of
Biological Chemistry, 276(38), 35352-35360.
Jiang, Y., He, X., Simonaro, C. M., Yi, B., & Schuchman, E. H. (2021). Acid ceramidase protects
against hepatic ischemia/reperfusion injury by modulating sphingolipid metabolism and reducing inflammation and oxidative stress. Frontiers in Cell and Developmental Biology, 9,
Al-Naimi, A., Toma, H., Hamad, S. G., & Ben Omran, T. (2022). Farber disease mimicking
juvenile idiopathic arthritis: the first reported case in Qatar and review of the literature. Case
Reports in Genetics, 2022.
Sridevi, N., & Sandhya Rani, M. (2015). Study of thyroid profile in infertile women. IOSR J
Pharm Biol Sci, 10(3), 57-61.
Elzobir, N. F., Hassan, E. E., Nassr, S. M. B., & AShrif, E. M. (2014). Assessment of serum levels
of prolactin in Sudanese female patients with primary hypothyroidism-Khartoum State,
Sudan. Asian Journal of Biomedical and Pharmaceutical Sciences, 4(32), 28.
Rotondi, M., Leporati, P., La Manna, A., Pirali, B., Mondello, T., Fonte, R., ... & Chiovato, L.
(2009). Raised serum TSH levels in patients with morbid obesity: is it enough to diagnose
subclinical hypothyroidism?. European journal of endocrinology, 160(3), 403-408.
Schäffler, A., Binart, N., Schölmerich, J., & Büchler, C. (2005). Hypothesis paper brain talks
with fat–evidence for a hypothalamic–pituitary–adipose axis?. Neuropeptides, 39(4), 363-
Seidah, N. G. (2011). The proprotein convertases, 20 years later. Proprotein Convertases, 23-
Kwakernaak, A. J., Lambert, G., Muller Kobold, A. C., & Dullaart, R. P. (2013). Adiposity blunts
the positive relationship of thyrotropin with proprotein convertase subtilisin-kexin type 9
levels in euthyroid subjects. Thyroid, 23(2), 166-172.
Levenson, A. E., Shah, A. S., Khoury, P. R., Kimball, T. R., Urbina, E. M., de Ferranti, S. D., ...
& Biddinger, S. B. (2017). Obesity and type 2 diabetes are associated with elevated PCSK9 levels
in young women. Pediatric diabetes, 18(8), 755-760.
Gagnon, A., Mahzari, M., Lochnan, H. A., & Sorisky, A. (2014). Acute TSH stimulation in vivo
does not alter serum PCSK9 levels. Thyroid Research, 7, 1-3.
Hammerschmidt, P., Ostkotte, D., Nolte, H., Gerl, M. J., Jais, A., Brunner, H. L., ... & Brüning,
J. C. (2019). CerS6-derived sphingolipids interact with Mff and promote mitochondrial
fragmentation in obesity. Cell, 177(6), 1536-1552.
Raichur, S., Wang, S. T., Chan, P. W., Li, Y., Ching, J., Chaurasia, B., ... & Summers, S. A.
(2014). CerS2 haploinsufficiency inhibits β-oxidation and confers susceptibility to dietinduced steatohepatitis and insulin resistance. Cell metabolism, 20(4), 687-695.
MacFarlane, I. A. (1997). Endocrine diseases and diabetes mellitus. Texbool of diabates, 64-1.
Gorska, M., Dobrzyn, A., Langfort, J., & Gorski, J. (2003). Effect of hypothyreosis on the
content of ceramides in rat tissues. Journal of physiology and pharmacology, 54(1), 89-97.